Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties

Finbarr O'Harte, Vadivel Parthsarathy, Christopher Hogg, Peter Flatt

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The adipokine, apelin has many biological functions but its activity is curtailed by rapid plasma degradation. Fatty acid derived apelin analogues represent a new and exciting avenue for the treatment of obesity-diabetes. This study explores four novel fatty acid modified apelin-13 analogues, namely, (Lys8GluPAL)apelin-13 amide, pGlu(Lys8GluPAL)apelin-13 amide, Lys8GluPAL(Tyr13)apelin-13 and Lys8GluPAL(Val13)apelin-13. Fatty acid modification extended the half-life of native apelin-13 to >24 h in vitro. pGlu(Lys8GluPAL)apelin-13 amide was the most potent insulinotropic analogue in BRIN-BD11 cells and isolated islets with maximal stimulatory effects of up to 2.7-fold (p <.001). (Lys8GluPAL)apelin-13 amide (1.9-fold) and Lys8GluPAL(Tyr13)apelin-13 (1.7-fold) were less effective, whereas Lys8GluPAL(Val13)apelin-13 had an inhibitory effect on insulin secretion. Similarly, pGlu(Lys8GluPAL)apelin-13 amide was most potent in increasing beta-cell intracellular Ca2+ concentrations (1.8-fold, p <.001) and increasing glucose uptake in 3T3-L1 adipocytes (2.3-fold, p <.01). Persistent biological action was observed with both pGlu(Lys8GluPAL)apelin-13 amide and (Lys8GluPAL)apelin-13 amide significantly reducing blood glucose (39–43%, p <.01) and enhancing insulin secretion (43–56%, p <.001) during glucose tolerance tests in diet-induced obese mice. pGlu(Lys8GluPAL)apelin-13 amide and (Lys8GluPAL)apelin-13 amide also inhibited feeding (28–40%, p <.001), whereas Lys8GluPAL(Val13)apelin-13 increased food intake (8%, p <.05) in mice. These data indicate that novel enzymatically stable analogues of apelin-13 may be suitable for future development as therapeutic agents for obesity-diabetes.
Original languageEnglish
Pages (from-to)165-173
Number of pages9
JournalBiochemical Pharmacology
Volume146
Early online date4 Oct 2017
DOIs
Publication statusPublished - 15 Dec 2017

Keywords

  • Adipokine
  • Apelin-13
  • Type 2 diabetes
  • Obesity
  • Feeding
  • Glucose homeostasis insulin release
  • Glucose uptake

Fingerprint Dive into the research topics of 'Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties'. Together they form a unique fingerprint.

  • Profiles

    No photo of Finbarr O'Harte

    Finbarr O'Harte

    Person: Academic

    Cite this